TCTR20230619004尚未招募2 期
A randomized controlled trial of Roxadustat in anemia of cirrhosis of liver and it's effects on HIF-1-alpha level.
Bangabandhu Seikh Mujib Medical University,Shahbag, Dhaka-1000,Bangladesh0 个研究点目标入组 105 人开始时间: 2023年6月19日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 105
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 Years 至 65 Years（—）
- 性别
- All
入选标准
- •1. Patients with cirrhosis of liver (Child pugh A or B)
- •2. Haemoglobin level > 7 gm/dl.
- •3. Age: 18 to 60 years.
排除标准
- •1. Patients with Child Pugh C liver cirrhosis
- •2. Haemoglobin level <7 gm/dl
- •3. Hepatocellular carcinoma
- •4. Pregnancy
- •5. Active variceal bleeding
- •6. Adult polycystic kidney disease
- •7. Hypo/Hyperthyroidism
- •8. Systemic Hypertension
- •9. Hyperkalemia
- •10. Patient with co-morbid condition (COPD, CKD, CCF, MI etc.)
- •11. Anemia caused by other haematological disorder associated with cirrhosis of liver.
研究者
相似试验
已完成
不适用
Study of effectiveness and safety of roxadustat for renal anemia in dialysis patientsRenal anemia in dialysis patientsJPRN-UMIN000039234agakubo Hospital8
进行中（未招募）
1 期
A randomised placebo controlled trial of rosuvastatin in systemic lupus erythematosus. - RCT of statin in SLESystemic lupus erythematosus.MedDRA version: 13.1 Level: LLT Classification code 10042944 Term: Systemic lupus erythematosis System Organ Class: 10028395 - Musculoskeletal and connective tissue disordersEUCTR2006-006214-16-GBImperial College64
招募中
不适用
Different Response to Roxadustat Treatment for Anemia Between Patients Undergoing Hemodialysis and Peritoneal Dialysis.End Stage Renal DiseaseJPRN-UMIN000039729Japanese Red Cross Asahikawa Hospital60
尚未招募
2 期
The effect of rosuvastatin in multiple sclerosisMultiple sclerosisIRCT20210211050323N3Hamedan University of Medical Sciences40
招募中
2 期
The effect of rosuvastatin in multiple sclerosisMultiple sclerosisIRCT20210211050323N2Hamedan University of Medical Sciences40